Long-term follow-up after furistem-ad treatment for atopic dermatitis
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This is a long-term follow-up study for people who already took part in the earlier FURESTEM-AD trial. It checks how safe the treatment is over time and looks at how well it continues to work for atopic dermatitis (a type of eczema).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been part of the earlier K0104 study that tested this treatment.
- You need to be willing and able to attend the required follow-up visits.
- You must not have joined any other clinical trial (with drugs or devices) since the previous study ended.
- You need to be considered suitable for the study by the research team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a long-term registry for adolescents and adults with atopic dermatitis (eczema) who are starting or switching to a systemic medication (a drug that works throughout the body). It will track how these treatments work in real life and how patients feel over time.
This trial tests a study drug (PF-08049820) for people with moderate to severe eczema who haven't found a suitable prescription treatment. It aims to see if the drug can improve skin symptoms and itching.
This study is a real-world registry that collects information from adults with atopic dermatitis (eczema) to track how newly started treatments work and how safe they are over time. It may help researchers and doctors better understand medication effects in everyday care.
This trial is testing a new investigational medicine (PF-07832837) for safety in healthy adults and in people with moderate to severe atopic dermatitis (eczema). It is a first-in-human study, so it looks at how well the body tolerates the medicine.
This observational study follows people with eczema (atopic dermatitis) and sometimes related allergies over time, even if they keep their usual medical treatments. It may help researchers better understand how these conditions change and what factors relate to symptoms.
This trial tests a new ointment called CU-10101. It will first be tested in healthy volunteers to check safety, and then in people with atopic dermatitis (eczema) to see how well it works for mild to moderate symptoms.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.